Exane BNP Paribas downgraded Aperam (APEMY) to Neutral from Outperform with a EUR 26.50 price target The firm says fundamentals for the steel stocks “remain fragile” with downside risks in the first half of 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam price target lowered to EUR 30.10 from EUR 30.30 at Morgan Stanley
- Aperam price target raised to EUR 34 from EUR 29 at Citi
- Aperam upgraded to Neutral from Underweight at JPMorgan
- Aperam price target raised to EUR 30.30 from EUR 30 at Morgan Stanley
- Aperam SA (APEMY) Reveals Q1 Dividend: Here’s the Essential Information
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue